Sljedeći

Auto Play

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 Pogledi • 06/15/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play